Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
Titel:
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
Auteur:
Moy, Ryan H. Greally, Megan Chou, Joanne F. Li, Jia Desai, Avni M. Chalasani, Sree B. Won, Elizabeth Kelsen, David P. Ilson, David H. Janjigian, Yelena Y. Capanu, Marinela Ku, Geoffrey Y.